The Journal of Invasive Cardiology

The Journal of Invasive Cardiology is a B2B brand intended for individuals with broad based interests in cardiovascular device industries. The brand content and editorial scope of the publication includes original research articles on clinical trials of devices and drugs used in the interventional suite and in post-intervention therapy, comparison of treatment modalities, in-depth reviews, expert commentaries, and brief communications focused on current innovations in clinical practice. Content is also available on the mobile app, and articles are available on the Website.

We also offer digital ad space on -

Business Name: HMP Global
Contact Name : Lam Wang
About Us: BPA Statement available upon request
Target Market: Cardiovascular device industries

Public discussion (0)

You must log in to send a new comment.